Titre : Prolapsus viscéral

Prolapsus viscéral : Questions médicales fréquentes

Termes MeSH sélectionnés :

Insulin Infusion Systems
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Prolapsus viscéral : Questions médicales les plus fréquentes", "headline": "Prolapsus viscéral : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Prolapsus viscéral : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-15", "dateModified": "2025-04-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Prolapsus viscéral" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Prolapsus d'organe pelvien", "url": "https://questionsmedicales.fr/mesh/D056887", "about": { "@type": "MedicalCondition", "name": "Prolapsus d'organe pelvien", "code": { "@type": "MedicalCode", "code": "D056887", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.300.842.624" } } }, "about": { "@type": "MedicalCondition", "name": "Prolapsus viscéral", "alternateName": "Visceral Prolapse", "code": { "@type": "MedicalCode", "code": "D014782", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Matthew D Barber", "url": "https://questionsmedicales.fr/author/Matthew%20D%20Barber", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Hans Peter Dietz", "url": "https://questionsmedicales.fr/author/Hans%20Peter%20Dietz", "affiliation": { "@type": "Organization", "name": "University of Sydney, Sydney, NSW, Australia." } }, { "@type": "Person", "name": "Shannon L Wallace", "url": "https://questionsmedicales.fr/author/Shannon%20L%20Wallace", "affiliation": { "@type": "Organization", "name": "Division of Urogynecology and Pelvic Floor Disorders, Department of Subspecialty Care for Women's Health, Women's Health Institute, Cleveland Clinic Foundation, Cleveland, OH. Electronic address: wallacs8@ccf.org." } }, { "@type": "Person", "name": "Eric R Sokol", "url": "https://questionsmedicales.fr/author/Eric%20R%20Sokol", "affiliation": { "@type": "Organization", "name": "Division of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Efficacy and safety of henagliflozin combined with continuous subcutaneous insulin infusion in the treatment of Chinese inpatients with type 2 diabetes mellitus based on a continuous glucose monitoring system: protocol of a multicentre, open-label, inpatient, randomised, controlled trial.", "datePublished": "2024-10-11", "url": "https://questionsmedicales.fr/article/39395826", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2024-084834" } }, { "@type": "ScholarlyArticle", "name": "Experiences of Patients Adopting and Adapting to Closed-Loop Insulin Delivery Systems (CLIDS).", "datePublished": "2022-12-21", "url": "https://questionsmedicales.fr/article/36541406", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/26350106221144957" } }, { "@type": "ScholarlyArticle", "name": "Automated Insulin Delivery Systems as a Treatment for Type 2 Diabetes Mellitus: A Review.", "datePublished": "2022-10-12", "url": "https://questionsmedicales.fr/article/36241017", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.eprac.2022.10.001" } }, { "@type": "ScholarlyArticle", "name": "An automatic deep reinforcement learning bolus calculator for automated insulin delivery systems.", "datePublished": "2024-07-02", "url": "https://questionsmedicales.fr/article/38956183", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-62912-4" } }, { "@type": "ScholarlyArticle", "name": "Assessing depressive symptoms and diabetes distress in Type 1 diabetic adults: A comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) users.", "datePublished": "2022-06-07", "url": "https://questionsmedicales.fr/article/35672927", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/13591053221098498" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "États anatomopathologiques", "item": "https://questionsmedicales.fr/mesh/D020763" }, { "@type": "ListItem", "position": 4, "name": "Prolapsus", "item": "https://questionsmedicales.fr/mesh/D011391" }, { "@type": "ListItem", "position": 5, "name": "Prolapsus d'organe pelvien", "item": "https://questionsmedicales.fr/mesh/D056887" }, { "@type": "ListItem", "position": 6, "name": "Prolapsus viscéral", "item": "https://questionsmedicales.fr/mesh/D014782" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Prolapsus viscéral - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Prolapsus viscéral", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Prolapsus viscéral", "description": "Comment diagnostique-t-on un prolapsus viscéral ?\nQuels tests sont utilisés pour évaluer un prolapsus ?\nQuels signes cliniques indiquent un prolapsus ?\nLe prolapsus peut-il être confondu avec d'autres conditions ?\nQuelle est l'importance de l'examen physique ?", "url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Insulin+Infusion+Systems&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Prolapsus viscéral", "description": "Quels sont les symptômes courants du prolapsus ?\nLe prolapsus peut-il causer des problèmes urinaires ?\nY a-t-il des symptômes digestifs associés ?\nComment le prolapsus affecte-t-il la sexualité ?\nLes symptômes varient-ils selon le type de prolapsus ?", "url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Insulin+Infusion+Systems&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Prolapsus viscéral", "description": "Comment prévenir le prolapsus viscéral ?\nLe tabagisme influence-t-il le prolapsus ?\nLes grossesses multiples augmentent-elles le risque ?\nL'âge joue-t-il un rôle dans le prolapsus ?\nLes activités physiques peuvent-elles aider ?", "url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Insulin+Infusion+Systems&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Prolapsus viscéral", "description": "Quels traitements sont disponibles pour le prolapsus ?\nQuand la chirurgie est-elle recommandée ?\nLes pessaires sont-ils efficaces ?\nQuels exercices aident à traiter le prolapsus ?\nY a-t-il des traitements médicaux non chirurgicaux ?", "url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Insulin+Infusion+Systems&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Prolapsus viscéral", "description": "Quelles complications peuvent survenir avec un prolapsus ?\nLe prolapsus peut-il entraîner des problèmes psychologiques ?\nY a-t-il un risque de récidive après traitement ?\nComment les infections sont-elles liées au prolapsus ?\nLe prolapsus peut-il affecter la fonction intestinale ?", "url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Insulin+Infusion+Systems&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Prolapsus viscéral", "description": "Quels sont les principaux facteurs de risque du prolapsus ?\nLe mode de vie influence-t-il le prolapsus ?\nLes antécédents chirurgicaux sont-ils un facteur ?\nLes troubles du collagène sont-ils liés au prolapsus ?\nLe stress physique a-t-il un impact ?", "url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Insulin+Infusion+Systems&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on un prolapsus viscéral ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par examen clinique et imageries comme l'échographie ou l'IRM." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer un prolapsus ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme l'examen pelvien et des études urodynamiques peuvent être réalisés." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent un prolapsus ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme une sensation de pesanteur ou des douleurs pelviennes peuvent indiquer un prolapsus." } }, { "@type": "Question", "name": "Le prolapsus peut-il être confondu avec d'autres conditions ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être confondu avec des infections ou des tumeurs pelviennes." } }, { "@type": "Question", "name": "Quelle est l'importance de l'examen physique ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'examen physique est crucial pour évaluer la gravité et le type de prolapsus." } }, { "@type": "Question", "name": "Quels sont les symptômes courants du prolapsus ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur pelvienne, incontinence et sensation de masse dans le vagin." } }, { "@type": "Question", "name": "Le prolapsus peut-il causer des problèmes urinaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut entraîner des difficultés à uriner ou des fuites urinaires." } }, { "@type": "Question", "name": "Y a-t-il des symptômes digestifs associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme la constipation ou des difficultés à déféquer peuvent survenir." } }, { "@type": "Question", "name": "Comment le prolapsus affecte-t-il la sexualité ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Il peut causer des douleurs pendant les rapports sexuels et une diminution du désir." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de prolapsus ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon qu'il s'agit d'un prolapsus vaginal, rectal ou utérin." } }, { "@type": "Question", "name": "Comment prévenir le prolapsus viscéral ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir un poids santé, faire des exercices pelviens et éviter de soulever des charges lourdes." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le prolapsus ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut affaiblir les tissus et augmenter le risque de prolapsus." } }, { "@type": "Question", "name": "Les grossesses multiples augmentent-elles le risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les grossesses multiples peuvent affaiblir les muscles pelviens et favoriser le prolapsus." } }, { "@type": "Question", "name": "L'âge joue-t-il un rôle dans le prolapsus ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de prolapsus augmente avec l'âge en raison de la perte de tonus musculaire." } }, { "@type": "Question", "name": "Les activités physiques peuvent-elles aider ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines activités comme le yoga peuvent renforcer le plancher pelvien et prévenir le prolapsus." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour le prolapsus ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des exercices de renforcement, des pessaires et la chirurgie." } }, { "@type": "Question", "name": "Quand la chirurgie est-elle recommandée ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est recommandée lorsque les symptômes sont sévères et ne répondent pas aux autres traitements." } }, { "@type": "Question", "name": "Les pessaires sont-ils efficaces ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les pessaires peuvent soutenir les organes et soulager les symptômes sans chirurgie." } }, { "@type": "Question", "name": "Quels exercices aident à traiter le prolapsus ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les exercices de Kegel renforcent les muscles pelviens et peuvent aider à réduire les symptômes." } }, { "@type": "Question", "name": "Y a-t-il des traitements médicaux non chirurgicaux ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements comme la physiothérapie pelvienne peuvent être bénéfiques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec un prolapsus ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent l'incontinence, des infections urinaires et des douleurs chroniques." } }, { "@type": "Question", "name": "Le prolapsus peut-il entraîner des problèmes psychologiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut causer de l'anxiété, de la dépression et affecter la qualité de vie." } }, { "@type": "Question", "name": "Y a-t-il un risque de récidive après traitement ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le prolapsus peut récidiver même après un traitement chirurgical ou non chirurgical." } }, { "@type": "Question", "name": "Comment les infections sont-elles liées au prolapsus ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les prolapsus peuvent augmenter le risque d'infections urinaires et vaginales." } }, { "@type": "Question", "name": "Le prolapsus peut-il affecter la fonction intestinale ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut entraîner des problèmes de constipation et de défécation difficile." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque du prolapsus ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'accouchement, l'obésité, le vieillissement et les antécédents familiaux." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le prolapsus ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et le surpoids augmentent le risque de prolapsus." } }, { "@type": "Question", "name": "Les antécédents chirurgicaux sont-ils un facteur ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des interventions chirurgicales pelviennes antérieures peuvent augmenter le risque de prolapsus." } }, { "@type": "Question", "name": "Les troubles du collagène sont-ils liés au prolapsus ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles du collagène peuvent affaiblir les tissus de soutien et favoriser le prolapsus." } }, { "@type": "Question", "name": "Le stress physique a-t-il un impact ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des efforts répétés ou un stress physique excessif peuvent contribuer au prolapsus." } } ] } ] }

Sources (10000 au total)

Efficacy and safety of henagliflozin combined with continuous subcutaneous insulin infusion in the treatment of Chinese inpatients with type 2 diabetes mellitus based on a continuous glucose monitoring system: protocol of a multicentre, open-label, inpatient, randomised, controlled trial.

The role of sodium-glucose cotransporter 2 inhibitors (SGLT2is) in diabetes treatment is expanding; however, few studies have investigated the efficacy and safety of combining SGLT2is with insulin pum... In this inpatient, open-label, multicentre, randomised, controlled trial, 200 patients with type 2 diabetes who have not received hypoglycaemic drugs will be randomly allocated at a 1:1 ratio to eithe... This study was approved by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University and is to be conducted in accordance with the Declaration of Helsinki and Good Clinical P... NCT05677334....

Experiences of Patients Adopting and Adapting to Closed-Loop Insulin Delivery Systems (CLIDS).

The purpose of the study was to explore the perspectives and experiences of adults with type 1 diabetes (T1DM) who are currently using the closed-loop insulin delivery system (CLIDS).... Eleven adults with T1DM who used closed-loop insulin pumps for at least 6 months participated in this qualitative descriptive study.... Four themes emerged from the rich descriptions: (1) striving for improvement, (2) missing a magic wand effect, (3) seeking support, and (4) barriers to adaptation. These themes represent both process-... To optimize CLIDS use and outcome, the antecedent conditions that contribute to patients' decision to adopt it must be understood. Then, interventions that focus on setting realistic expectations must...

Automated Insulin Delivery Systems as a Treatment for Type 2 Diabetes Mellitus: A Review.

Approximately 6.3% of the worldwide population has type 2 diabetes mellitus (T2DM), and the number of people requiring insulin is increasing. Automated insulin delivery (AID) systems integrate continu... We performed a review of AID systems with a focus on the T2DM population.... In 5 randomized controlled trials, AID systems improve time in range and reduce glycemic variability, without increasing insulin requirements or the risk of hypoglycemia.... AID systems in T2DM are safe and effective in hospitalized and closely monitored settings. Home studies of longer duration are required to assess for long-term benefit and identify target populations ...

Assessing depressive symptoms and diabetes distress in Type 1 diabetic adults: A comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) users.

This cross-sectional observational study assesses differences in depressive symptoms and diabetes-distress between adults with type 1 diabetes using continuous subcutaneous insulin infusion (CSII) or ...

Use of continuous subcutaneous insulin infusion versus multiple daily injections in emerging adults with type 1 diabetes is associated with better clinical engagement but not glycaemic control.

Limited studies have compared outcomes between emerging adults with type 1 diabetes mellitus (T1D) attending a diabetes transition support programme using multiple daily injections (MDI) or continuous... To assess glycaemic control and service utilisation in emerging adults with T1D on MDI or CSII attending a young adult diabetes clinic (YAC).... A retrospective cohort analysis was conducted from January 2013 to December 2015. Data collected included clinic visits per year, after-hours mobile telephone use, diabetic ketoacidosis (DKA) admissio... Over 3 years, 318 youth with T1D (176 MDI, 121 CSII, 21 switched from MDI to CSII) attended our YAC. Aggregated mean HbA1c levels remained similar between modalities (CSII 9.1% vs MDI 9.3%; P = 0.23);... In our YAC cohort, glycaemic control in CSII and MDI users was similar but well below recommended international glycaemic targets (HbA1c level < 7.0%). Despite increased clinical engagement occurring ...

Simulation-driven optimization of insulin therapy profiles in a commercial hybrid closed-loop system.

Automated insulin delivery (AID) has represented a breakthrough in managing type 1 diabetes (T1D), showing safe and effective glucose control extensively across the board. However, metabolic variabili... Closed-loop data are generated using the full adult cohort of the UVA/Padova T1D simulation platform in diverse glycemic scenarios. For each subject, daily records are processed and used to estimate a... Simulations reveal that the proposed IRO approach was able to improve glucose control over time by safely mitigating the risks for both hypo- and hyperglycemia. Furthermore, smaller changes were recom... The use of reliable simulation-driven tools capable of accurately reproducing field-collected data and predicting changes can substantially shorten the process of optimizing insulin therapy, adjusting...

Comparison of continuous subcutaneous insulin infusion treatment and multiple daily injection treatment on the progression of diabetic complications in Japanese patients with juvenile-onset type 1 diabetes mellitus.

To evaluate whether continuous subcutaneous insulin infusion attenuates the progression of diabetic complications, we retrospectively extracted data from 35 individuals who had developed type 1 diabet...

Effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections on glycaemic control among older adults with type 2 diabetes: protocol for systematic review and meta-analysis.

Insulin therapy plays an irreplaceable role in glycaemic control among older adults with type 2 diabetes mellitus (T2DM) and can be administered by either multiple daily injections (MDI) of insulin or... PubMed, Medline, Cochrane Library, Web of Science core collection, China National Knowledge Infrastructure (CNKI), Wan Fang Database, Chinese Science and Technology Journal Database (VIP) and Chinese ... As this study will not contain personal information, ethical approval will not be required. The results of the study will be published in a peer-reviewed journal or at relevant conference.... CRD42021283729....